Internal Medicine NewsFDA Approves Ustekinumab Biosimilar Steqeyma, the Seventh of Its KindDecember 19, 2024DermatologyRheumatologyGastroenterologyMusculoskeletal Disorders
Internal Medicine NewsNew Cause of Sexually Transmitted Fungal Infection Reported in MSMNovember 13, 2024Infectious DiseasesDermatology
Internal Medicine NewsDuloxetine Bottles Recalled by FDA Because of Potential CarcinogenOctober 28, 2024DepressionPainDiabetesMental Health
Internal Medicine NewsTirzepatide Shortage Resolved? FDA Says Yes, Compounders NoOctober 7, 2024ObesityEndocrinology
Internal Medicine NewsFDA OKs Next-Gen Cologuard Test for CRC ScreeningOctober 4, 2024GastroenterologyOncology
Internal Medicine NewsFDA Approves Ustekinumab Biosimilar OtulfiOctober 3, 2024GastroenterologyImmunologyRheumatology
Internal Medicine NewsBimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial SpondyloarthritisSeptember 24, 2024DermatologyRheumatology
Internal Medicine NewsFDA OKs Adjuvant Ribociclib in Earlier Stage Breast CancerSeptember 23, 2024Breast CancerOncologyWomen's Health
Internal Medicine NewsBenralizumab Now FDA Approved to Treat EGPA VasculitisSeptember 19, 2024Rare DiseasesRheumatologyNephrologyPulmonologyAsthma
Internal Medicine NewsFDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer IndicationsSeptember 17, 2024Mixed TopicsOncologyHepatologyDermatologyPulmonology
Internal Medicine NewsFDA Grants Livdelzi Accelerated Approval for Primary Biliary CholangitisAugust 14, 2024HepatologyGastroenterology
Internal Medicine NewsFDA Expands Dostarlimab-gxly Approval for Endometrial CancerAugust 2, 2024OncologyWomen's Health
Internal Medicine NewsCompounded Semaglutide Overdoses Tied to HospitalizationsJuly 30, 2024ObesityDiabetes
Internal Medicine NewsBreakthrough Blood Test for Colorectal Cancer Gets Green LightJuly 30, 2024GastroenterologyPreventive CareOncology
Internal Medicine NewsFDA OKs Voquezna for Heartburn Relief in Nonerosive Gastroesophageal Reflux DiseaseJuly 19, 2024GastroenterologyHeartburn/Acid Reflux
